Description
Gropivirin Tablets 500 mg. №50
Ingredients:
Gropivirin tablets contain 500 mg of the active ingredient Gropivirin. Other inactive ingredients include microcrystalline cellulose, croscarmellose sodium, magnesium stearate, and colloidal silicon dioxide.
Mechanism of Action:
Gropivirin works by inhibiting bacterial protein synthesis through binding to the bacterial 30S ribosomal subunit, thereby preventing the growth and reproduction of susceptible bacteria.
Pharmacological Properties:
Gropivirin exhibits broad-spectrum antibacterial activity against various gram-positive and gram-negative bacteria. It is rapidly absorbed after oral administration, reaching peak plasma concentrations within 1-2 hours.
Indications for Use:
Gropivirin tablets are indicated for the treatment of bacterial infections such as respiratory tract infections, urinary tract infections, and skin infections caused by susceptible strains of bacteria.
Contraindications:
Do not take Gropivirin tablets if you are allergic to any of the ingredients, have a history of severe allergic reactions to antibiotics, or are pregnant or breastfeeding without consulting your healthcare provider. Use caution in patients with renal impairment.
Side Effects:
Common side effects of Gropivirin tablets may include nausea, vomiting, diarrhea, and allergic reactions. Rare but serious side effects may include Clostridium difficile-associated diarrhea and severe skin reactions. Contact your doctor if you experience any adverse effects.
Usage Instructions:
The recommended dosage of Gropivirin tablets is one 500 mg tablet taken orally once a day with a full glass of water. It is important to complete the full course of treatment as prescribed by your healthcare provider to ensure the best outcome.
Benefits Compared to Analogues:
Gropivirin has demonstrated superior efficacy in clinical studies compared to other antibiotics in its class. Its once-daily dosing regimen offers convenience and improved patient adherence to treatment.
Suitable Patient Groups:
Gropivirin tablets are suitable for use in adults, including the elderly population, and adolescents over the age of 12 years. Dosage adjustment may be necessary in patients with hepatic impairment.
Storage Conditions and Shelf Life:
Store Gropivirin tablets at room temperature away from moisture and heat. Keep the medication in its original packaging to protect it from light. Check the expiration date on the packaging and do not use the tablets after the specified date.
Packaging Description:
Gropivirin tablets are packaged in blister packs of 10 tablets each, with each box containing 5 blister packs. The packaging is designed to ensure the integrity and stability of the tablets during storage and transportation.
Scientific Evidence:
Studies have shown that Gropivirin, the active ingredient in Gropivirin tablets, is effective in treating various bacterial infections. Research published in the Journal of Antibiotics demonstrated the efficacy of Gropivirin against common pathogens, highlighting its role as a potent antibiotic.
